Why Postpartum Depression Is Still Off the Radar in Pregnancy Care
LeThenia Joy Baker, MD, explains why PPD is often overlooked compared to physical pregnancy conditions like gestational diabetes.
At the 2025 American College of Obstetricians and Gynecologists (ACOG) Clinical & Scientific Meeting, LeThenia Joy Baker, MD, of Wellstar West Georgia Medical Center in LaGrange, GA, talked with Patient Care about her presentation on the barriers to postpartum depression (PPD) diagnosis. While clinicians routinely screen for conditions like gestational diabetes, mental health issues often go unaddressed. Baker points out that mental health changes during and after pregnancy simply aren’t on every provider’s radar, especially when there are pressing physical health concerns to manage.
Read all the Patient Care coverage of ACOG 2025.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Lebrikizumab Demonstrates Efficacy, Safety in Patients With Skin of Color With AD
June 11th 2025RAD 2025. Lebrikizumab improved skin clearance, itch, and pigmentation in patients with skin of color and atopic dermatitis, with strong safety data through 24 weeks, according to late-breaking data.
